welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
study id #: NCT02198092
condition: Familial Adenomatous Polyposis, Map Syndrome, Lynch Syndrome, HNPCC, Colorectal Cancer
This is an observational, case-control study evaluating the quantitative level of Septin9 in plasma pre- and post-colectomy in hereditary colorectal cancer (CRC) syndrome patients (Familial Adenomatous Polyposis (FAP), Lynch syndrome (also known as HNPCC), and Multiple Adenomatous Polyposis (MAP, also known as MYK/MYH) cases) and genetically related FAP-family members as controls and references.
intervention: Other: Epi proColon Testing
start date: July 2014
estimated completion: August 2020
last updated: February 7, 2018
phase of development: Not Available
size / enrollment: 46
study design: Observational Model: Case Control, Time Perspective: Prospective
- Septin9 Plasma Levels [ Time Frame:Up to 2 years ] [ Designated as safety issue: No ]
The primary objective of the study is the observational analysis of quantitative Septin9 plasma levels over time in hereditary CRC syndrome patients pre- and post-colectomy.
- Septin9 Plasma Levels Versus Polyps [ Time Frame:Up to 2 years ] [ Designated as safety issue:No ]
Correlation of quantitative Septin9 plasma levels with the approx. number of polyps
- Pre- and Post-Colectomy Colonic Epithelial Cell Numbers [ Time Frame:Up to 2 years ] [ Designated as safety issue: No ]
Correlation of circulating colonic epithelial cell number pre- and post-colectomy
- Septin9 Levels Versus Circulating Colonic Epithelial Cell Numbers [ Time Frame:Up to 2 years ] [ Designated as safety issue: No ]
Correlation of circulating colonic epithelial cell number with Septin9 levels
- Informed consent provided
- Age > or = to 18 years of age
- Patient group FAP
- Clinical diagnosis of familial adenomatous polyposis
- Patient group Lynch syndrome Clinical diagnosis of Lynch syndrome
- Patient group MAP
- Clinical diagnosis of MYH-associated polyposis and presence of more than 20 colon polyps
- Control group (FAP)
- Genetically related family member of patient
- Patients: Able and willing to attend routine follow-up as advised
- Controls, i.e. relatives of patients: Willingness to give blood at each routine follow-up as advised for the diseased relative
- Known infection with Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), or Hepatitis C Virus (HCV)
- Current diagnosis of colorectal cancer
expertly curated content related to this topic
Enhanced Cyclooxygenase-2 Expression in Sporadic and Familial Adenomatous Polyposis of the Human ColonBACKGROUND : The cyclooxygenase (COX) en...
Intestinal Polyps and Polyposis: State-of-the-Art, Multidisciplinary Publication on Polyps and PolyposisNowadays, we are dealing more frequently...
Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...
A Prospective Multicenter Phase II Study of Sunitinib in Patients With Advanced Aggressive FibromatosisSeveral studies have reported that imati...
Risk of Colorectal Cancer For Carriers of Mutations in MutYH, With and Without a Family History of CancerWe studied 2332 individuals with monoall...
Studies of the Foregut in Patients with Familial Adenomatous Polyposis (FAP): The Clinical Problem, Management, and ...Thirty-eight published papers, co-author...
Study provides better understanding of sequence of genetic events in colorectal cancer premalignancyWhole-exome sequencing of both colorecta...